Vyripharm Enterprises Patents – Insights & Stats (Updated 2023)

Vyripharm Enterprises has a total of 28 patents globally, out of which 8 have been granted. Of these 28 patents, more than 82% patents are active. United States of America is where Vyripharm Enterprises has filed the maximum number of patents, followed by Europe and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Vyripharm Enterprises.

Vyripharm Enterprises was founded in the year 2014. The Company is a biotechnology research firm that offers personalized medicine and drug development services.

Do read about some of the most popular patents of Vyripharm Enterprises which have been covered by us in this article and also you can find Vyripharm Enterprises patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Vyripharm Enterprises patent portfolio.

How many patents does Vyripharm Enterprises have?

Vyripharm Enterprises has a total of 28 patents globally. These patents belong to 2 unique patent families. Out of 28 patents, 23 patents are active.

How Many Patents did Vyripharm Enterprises File Every Year?

Vyripharm Enterprises Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantVyripharm Enterprises Applications FiledVyripharm Enterprises Patents Granted
20234
20222
20213
202013
201921
20188
201711
20141

How many Vyripharm Enterprises patents are Alive/Dead?

Vyripharm Enterprises Patent Portfolio

How Many Patents did Vyripharm Enterprises File in Different Countries?

Vyripharm Enterprises Worldwide Patent Filing

Countries in which Vyripharm Enterprises Filed Patents

CountryPatents
United States Of America4
South Africa3
China2
Mexico2
Korea (South)2
Europe2
Peru2
Canada2
India2
Australia2
Israel2
Hong Kong (S.A.R.)1
Eurasia1

Where are Research Centres of Vyripharm Enterprises Patents Located?

The Research Centre for all the Vyripharm Enterprises patents is the United States of America.

Best Vyripharm Enterprises Patents

US9632069B2 is the most popular patent in the Vyripharm Enterprises portfolio. It has received 16 citations so far from companies like Enigami Systems, Inc., Radient Technologies Innovations Inc. and Poshmark, Inc.

What Percentage of Vyripharm Enterprises US Patent Applications were Granted?

Vyripharm Enterprises (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Vyripharm Enterprises patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Vyripharm Enterprises?

Law FirmTotal ApplicationsSuccess Rate
Houston Office Of4100.00%

List of Vyripharm Enterprises Patents

Vyripharm Enterprises PatentsTitle
US11378564B2Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products
US10222361B2Integrated Systems And Methods Of Evaluating Cannabis And Cannabinoid Products For Public Safety, Quality Control And Quality Assurance Purposes
US9632069B2Integrated Systems And Methods Of Evaluating Cannabis And Cannabinoid Products For Public Safety, Quality Control And Quality Assurance Purposes
EP3706065A1Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products
CN111653332ACannabis Product Integrated Comprehensive Management System And Method
CN111065391ACompositions Containing Cannabinoid Analog Conjugates And Methods Of Use
CA3068720A1Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use
CA3070538A1Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use
AU2018302155B2Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use
AU2020200390A1Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products
HK40037285ASystems And Methods For Integrated And Comprehensive Management Of Cannabis Products
IN202017003522ACompositions Containing Cannabinoid Analog Conjugates And Methods Of Use
MX403065BCompositions Containing Analogue Conjugates Of Cannabinoids And Methods Of Use
ZA202001552BSystems And Methods For Integrated And Comprehensive Management Of Cannabis Products
ZA202106450BSystems And Methods For Integrated And Comprehensive Management Of Cannabis Products
ZA202106452BSystems And Methods For Integrated And Comprehensive Management Of Cannabis Products
MX2020000865ASystems And Methods For Integrated And Comprehensive Management Of Cannabis Products.
KR1020200106449ASystems And Methods For Integrated And Comprehensive Management Of Cannabis Products
PE0008662020A1Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use
EA202090116A1Compositions Containing Cannabinoid Analogue Conjugates And Methods Of Use
IL272060ACompositions Containing Cannabinoid Analog Conjugates And Methods Of Use
IL271681ASystems And Methods For Integrated And Comprehensive Management Of Cannabis Products
US20210080441A1Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use
EP3654971A4Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use
WO2019018536A1Compositions Containing Cannabinoid Analog Conjugates And Methods Of Use
IN202014003523A“Systems And Methods For Integrated And Comprehensive Management Of Cannabis Products”
KR1020200031663ACompositions Comprising Cannabinoid Analog Conjugates And Methods Of Use

What are Vyripharm Enterprises key innovation segments?

What Technologies are Covered by Vyripharm Enterprises?

The chart below distributes patents filed by Vyripharm Enterprises in different countries on the basis of the technology protected in patents. It also represents the markets where Vyripharm Enterprises thinks it’s important to protect particular technology inventions.

R&D Focus: How has Vyripharm Enterprises search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Vyripharm Enterprises?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.